Arkansas SB 639: TO AUTHORIZE OFF-LABEL USE OF DRUG TREATMENTS TO TREAT PATIENTS DIAGNOSED WITH PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION.

Status: Notification that SB639 is now Act 1054 (as of 2021-04-30)

State: Arkansas · Session: 2021 · Bill: SB 639

Sponsors: Cloud, K. Hammer

View Arkansas SB 639 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.